Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Soucek

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Nature Medicine|October 2, 2007
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumorsLaura Soucek, Elizabeth R Lawlor, Darya Soto, et al.
Genes & Development|April 12, 2011
Endogenous Myc maintains the tumor microenvironmentNicole M Sodir, Lamorna Brown Swigart, Anthony N Karnezis, et al.
Cancer Research|May 3, 2006
Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesisElizabeth R Lawlor, Laura Soucek, Lamorna Brown-Swigart, et al.
Plos One|August 4, 2011
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapyMauro Savino, Daniela Annibali, Nicoletta Carucci, et al.
Cancer Cell|August 15, 2006
Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanismsAndrew Finch, Julia Prescott, Ksenya Shchors, et al.
Nature Genetics|June 1, 2005
Temporal dissection of p53 function in vitro and in vivoMaria A Christophorou, Dionisio Martin-Zanca, Laura Soucek, et al.
FEBS Letters|January 5, 2002
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interactionGeorgia Mandolesi, Silvia Gargano, Maria Pennuto, et al.
Open Biology|March 17, 2026
A CDCA2-MYC positive feedback loop controls cancer cells survivalKonstantinos Stamatiou, Lorena Ligammari, Malki Bothota, et al.
Anticancer Research|November 2, 2010
Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of MycTakuya Fukazawa, Yutaka Maeda, Junji Matsuoka, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinomaLaura Soucek, Joseph J Buggy, Roderik Kortlever, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Nature Medicine|October 2, 2007
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumorsLaura Soucek, Elizabeth R Lawlor, Darya Soto, et al.
Genes & Development|April 12, 2011
Endogenous Myc maintains the tumor microenvironmentNicole M Sodir, Lamorna Brown Swigart, Anthony N Karnezis, et al.
Cancer Research|May 3, 2006
Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesisElizabeth R Lawlor, Laura Soucek, Lamorna Brown-Swigart, et al.
Plos One|August 4, 2011
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapyMauro Savino, Daniela Annibali, Nicoletta Carucci, et al.
Cancer Cell|August 15, 2006
Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanismsAndrew Finch, Julia Prescott, Ksenya Shchors, et al.
Nature Genetics|June 1, 2005
Temporal dissection of p53 function in vitro and in vivoMaria A Christophorou, Dionisio Martin-Zanca, Laura Soucek, et al.
FEBS Letters|January 5, 2002
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interactionGeorgia Mandolesi, Silvia Gargano, Maria Pennuto, et al.
Open Biology|March 17, 2026
A CDCA2-MYC positive feedback loop controls cancer cells survivalKonstantinos Stamatiou, Lorena Ligammari, Malki Bothota, et al.
Anticancer Research|November 2, 2010
Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of MycTakuya Fukazawa, Yutaka Maeda, Junji Matsuoka, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinomaLaura Soucek, Joseph J Buggy, Roderik Kortlever, et al.
Pageof 8